Home › Funds › Citigroup Inc › GLPG
Citigroup Inc position in GLPG
LAKEFRONT BIOTHERAPEUTICS NV
Latest position (Q2 2026)354 sh
Reported value held$10.61K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 8.11K | $426.00K | New |
| Q4 2021 | 7.33K | $404.00K | Reduce |
| Q1 2022 | 5.95K | $369.00K | Reduce |
| Q2 2022 | 1.47K | $82.00K | Reduce |
| Q3 2022 | 1.34K | $58.00K | Reduce |
| Q4 2022 | 1.73K | $76.91K | Add |
| Q1 2023 | 1.34K | $51.78K | Reduce |
| Q2 2023 | 1.24K | $50.22K | Reduce |
| Q3 2023 | 90.69K | $3.13M | Add |
| Q4 2023 | 187.85K | $7.64M | Add |
| Q1 2024 | 114.74K | $3.69M | Reduce |
| Q2 2024 | 30.21K | $748.50K | Reduce |
| Q3 2024 | 30.05K | $865.08K | Reduce |
| Q4 2024 | 29.86K | $821.01K | Reduce |
| Q1 2025 | 29.70K | $746.01K | Reduce |
| Q2 2025 | 776 | $21.72K | Reduce |
| Q3 2025 | 73.85K | $2.56M | Add |
| Q4 2025 | 404 | $13.21K | Reduce |
| Q1 2026 | 498 | $14.94K | Add |
| Q2 2026 | 354 | $10.61K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding GLPG
- BlackRock Inc 338.15K sh · $10.14M · Q2 2026
- D. E. Shaw & Co 197.84K sh · $5.93M · Q2 2026
- Millennium Management 181.09K sh · $5.43M · Q2 2026
- Two Sigma Investments 81.75K sh · $2.45M · Q2 2026
- Morgan Stanley 37.68K sh · $1.13M · Q2 2026
- Marshall Wace 32.40K sh · $971.32K · Q2 2026
- Geode Capital Management 10.15K sh · $304.30K · Q2 2026
- JPMorgan Chase & Co 1.32K sh · $39.16K · Q2 2026
- Wells Fargo & Co 1.20K sh · $35.98K · Q2 2026
- Fidelity Management & Research (FMR) 1 sh · $30 · Q2 2026